ENDO2024 BOSTON
BCCC Seminar
Republic of Palau Ministry of Health and Human Services
From Science to Implementation. From Concepts to Business.
Based on experience in bioinformatics, web and system development, blockchain, compliance checks, and the medical and biotech fields, this page introduces activities that connect university-originated research to commercialization, social implementation, and international expansion.
Professor Hideto Kojima and Fumihisa Kojima
About Fumihisa Kojima.
This page introduces the profile of Fumihisa Kojima and his current activities. As Representative Director of Biozipcode Inc., he is advancing commercialization, fundraising, intellectual property utilization, and collaboration with domestic and international partners to bring research outcomes in the medical and biotech fields to society. Drawing also on knowledge of AI, computational science, and Web3, he plays a role in connecting research with social implementation.
Drug Discovery Research Using Molecular Dynamics
Career & Timeline.
From his student years studying bioinformatics, Fumihisa Kojima has expanded his activities into web production, system development, crypto assets, AML and compliance, and medical and biotech businesses centered on Biozipcode™. This page presents, in chronological order, how his current initiatives have emerged from accumulated experience in an easy-to-understand format.
GPU-Intensive Supercomputing Business
Positions & Affiliated Companies.
This page organizes the companies, positions, and related projects with which Fumihisa Kojima is currently involved or has been involved in the past. It clearly explains the relationships and his role in Biozipcode Inc., Studio Makyu Co., Ltd., Biozipcode Group–related projects, and other initiatives.
Protein 3D Structure Modeling
Technology & Business Journey.
This page introduces Fumihisa Kojima’s technology and business journey across web, computational science, blockchain, and medical research. From web production to GPGPU, AML, biotech, and Web3, it outlines how different technology domains have led to his current medical and overseas expansion businesses.